fibrosis: affect development

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents complication
Weight: 0.54
, problem
Weight: 0.53
, condition
Weight: 0.49
, disease
Weight: 0.48
, feature
Weight: 0.48
Siblings cystic fibrosis
Weight: 0.36
, pulmonary edema
Weight: 0.35
, myocardial infarction
Weight: 0.35
, pelvic inflammatory disease
Weight: 0.35
, atherosclerosis
Weight: 0.34

Related properties

Property Similarity
affect development 1.00
affect growth 0.82
solve important for child development 0.79
affect health 0.78
affect system 0.78
affect needs 0.76
affect social needs 0.76
affect human health 0.76
affect oil changes 0.75
develop 0.75

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Plausibility inference from child typicality

0.22
Rule weight: 0.66
Evidence weight: 0.43
Similarity weight: 0.78
Evidence: 0.22
Plausible(disease, affect health)
Evidence: 0.73
¬ Typical(fibrosis, affect development)
0.21
Rule weight: 0.66
Evidence weight: 0.42
Similarity weight: 0.76
Evidence: 0.20
Plausible(disease, affect human health)
Evidence: 0.73
¬ Typical(fibrosis, affect development)

Plausibility inheritance from parent to child

0.07
Rule weight: 0.09
Evidence weight: 0.94
Similarity weight: 0.78
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.22
¬ Plausible(disease, affect health)
0.07
Rule weight: 0.09
Evidence weight: 0.95
Similarity weight: 0.76
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.20
¬ Plausible(disease, affect human health)

Remarkability exclusitivity betweem a parent and a child

0.11
Rule weight: 0.58
Evidence weight: 0.25
Similarity weight: 0.78
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.99
¬ Remarkable(disease, affect health)
0.11
Rule weight: 0.58
Evidence weight: 0.25
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.99
¬ Remarkable(disease, affect human health)

Remarkability exclusitivity between siblings

0.05
Rule weight: 0.13
Evidence weight: 0.48
Similarity weight: 0.82
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.68
¬ Remarkable(cystic fibrosis, affect growth)
0.05
Rule weight: 0.13
Evidence weight: 0.48
Similarity weight: 0.75
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.68
¬ Remarkable(atherosclerosis, develop)
0.04
Rule weight: 0.13
Evidence weight: 0.33
Similarity weight: 1.00
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.88
¬ Remarkable(cystic fibrosis, affect development)
0.04
Rule weight: 0.13
Evidence weight: 0.40
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.80
¬ Remarkable(cystic fibrosis, affect social needs)
0.04
Rule weight: 0.13
Evidence weight: 0.35
Similarity weight: 0.78
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.85
¬ Remarkable(cystic fibrosis, affect system)
0.03
Rule weight: 0.13
Evidence weight: 0.33
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.89
¬ Remarkable(cystic fibrosis, affect needs)

Remarkability from parent implausibility

0.28
Rule weight: 0.42
Evidence weight: 0.86
Similarity weight: 0.78
Evidence: 0.22
Plausible(disease, affect health)
Evidence: 0.76
Remarkable(fibrosis, affect development)
Evidence: 0.74
¬ Plausible(fibrosis, affect development)
0.27
Rule weight: 0.42
Evidence weight: 0.85
Similarity weight: 0.76
Evidence: 0.20
Plausible(disease, affect human health)
Evidence: 0.76
Remarkable(fibrosis, affect development)
Evidence: 0.74
¬ Plausible(fibrosis, affect development)

Remarkability from sibling implausibility

0.59
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 1.00
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.88
Remarkable(cystic fibrosis, affect development)
Evidence: 0.61
¬ Plausible(cystic fibrosis, affect development)
0.47
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.82
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.68
Remarkable(cystic fibrosis, affect growth)
Evidence: 0.63
¬ Plausible(cystic fibrosis, affect growth)
0.46
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.85
Remarkable(cystic fibrosis, affect system)
Evidence: 0.60
¬ Plausible(cystic fibrosis, affect system)
0.45
Rule weight: 0.60
Evidence weight: 0.98
Similarity weight: 0.76
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.89
Remarkable(cystic fibrosis, affect needs)
Evidence: 0.59
¬ Plausible(cystic fibrosis, affect needs)
0.44
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.76
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.80
Remarkable(cystic fibrosis, affect social needs)
Evidence: 0.75
¬ Plausible(cystic fibrosis, affect social needs)
0.43
Rule weight: 0.60
Evidence weight: 0.96
Similarity weight: 0.75
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.68
Remarkable(atherosclerosis, develop)
Evidence: 0.52
¬ Plausible(atherosclerosis, develop)

Salient implies Plausible

0.22
Rule weight: 0.28
Evidence weight: 0.78
Similarity weight: 1.00
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.86
¬ Salient(fibrosis, affect development)

Similarity expansion

0.65
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.82
Evidence: 0.86
Salient(fibrosis, affect development)
Evidence: 0.56
¬ Salient(fibrosis, affect growth)
0.62
Rule weight: 0.85
Evidence weight: 0.88
Similarity weight: 0.82
Evidence: 0.76
Remarkable(fibrosis, affect development)
Evidence: 0.49
¬ Remarkable(fibrosis, affect growth)
0.61
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.78
Evidence: 0.73
Typical(fibrosis, affect development)
Evidence: 0.31
¬ Typical(fibrosis, affect system)
0.61
Rule weight: 0.85
Evidence weight: 0.91
Similarity weight: 0.78
Evidence: 0.86
Salient(fibrosis, affect development)
Evidence: 0.64
¬ Salient(fibrosis, affect system)
0.60
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.82
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.55
¬ Plausible(fibrosis, affect growth)
0.59
Rule weight: 0.85
Evidence weight: 0.89
Similarity weight: 0.78
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.44
¬ Plausible(fibrosis, affect system)
0.58
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.82
Evidence: 0.73
Typical(fibrosis, affect development)
Evidence: 0.63
¬ Typical(fibrosis, affect growth)
0.53
Rule weight: 0.85
Evidence weight: 0.79
Similarity weight: 0.78
Evidence: 0.76
Remarkable(fibrosis, affect development)
Evidence: 0.86
¬ Remarkable(fibrosis, affect system)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.93
Similarity weight: 1.00
Evidence: 0.86
Salient(fibrosis, affect development)
Evidence: 0.73
¬ Typical(fibrosis, affect development)
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.81
Similarity weight: 1.00
Evidence: 0.74
Plausible(fibrosis, affect development)
Evidence: 0.73
¬ Typical(fibrosis, affect development)

Typicality and Rermarkability incompatibility between a parent and a child

0.39
Rule weight: 0.51
Evidence weight: 0.98
Similarity weight: 0.78
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.03
¬ Typical(disease, affect health)
0.38
Rule weight: 0.51
Evidence weight: 0.99
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.01
¬ Typical(disease, affect human health)

Typicality and Rermarkability incompatibility between siblings

0.09
Rule weight: 0.14
Evidence weight: 0.63
Similarity weight: 1.00
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.49
¬ Typical(cystic fibrosis, affect development)
0.07
Rule weight: 0.14
Evidence weight: 0.64
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.47
¬ Typical(cystic fibrosis, affect needs)
0.07
Rule weight: 0.14
Evidence weight: 0.61
Similarity weight: 0.78
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.51
¬ Typical(cystic fibrosis, affect system)
0.06
Rule weight: 0.14
Evidence weight: 0.62
Similarity weight: 0.75
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.51
¬ Typical(atherosclerosis, develop)
0.06
Rule weight: 0.14
Evidence weight: 0.52
Similarity weight: 0.82
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.64
¬ Typical(cystic fibrosis, affect growth)
0.05
Rule weight: 0.14
Evidence weight: 0.46
Similarity weight: 0.76
Evidence: 0.76
¬ Remarkable(fibrosis, affect development)
Evidence: 0.72
¬ Typical(cystic fibrosis, affect social needs)

Typicality inheritance from parent to child

0.38
Rule weight: 0.48
Evidence weight: 0.99
Similarity weight: 0.78
Evidence: 0.73
Typical(fibrosis, affect development)
Evidence: 0.03
¬ Typical(disease, affect health)
0.37
Rule weight: 0.48
Evidence weight: 1.00
Similarity weight: 0.76
Evidence: 0.73
Typical(fibrosis, affect development)
Evidence: 0.01
¬ Typical(disease, affect human health)